Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_baee372c55802742f9582e25c15ff11a |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D263-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-091 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-2408 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-1411 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C217-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-141 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C271-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D263-02 |
filingDate |
2014-05-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2015-02-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e46c3b35639c467751ce44a83ceca627 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d47c6ca469cf24eda8eea7252d3fd0e2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6f9cda7d582678d067f2df37a6d5c3f6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_36e1940a2dac79c5145fc8098f2ec972 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_12450e1f7adaf476c6792bf6eb869db8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_79bdf053238903f1a390d940128bc8a0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_760495cf7066146d2bd66cb27acf2ba0 |
publicationDate |
2015-02-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-8962857-B2 |
titleOfInvention |
Compounds for preparing immunological adjuvant |
abstract |
The present invention provides methods for preparing TLR-4 receptor agonist E6020: n n n n n n n n n n n n and stereoisomers thereof, which compounds are useful as an immunological adjuvants when co-administered with antigens such as vaccines for bacterial and viral diseases. Also provided are synthetic intermediates. |
priorityDate |
2005-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |